RealFeedApp Avaí Bio and Austrianova formed a 50/50 joint venture
A peer-reviewed article in Frontiers in Aging details the Klothonova platform, which uses cell-encapsulation to achieve long-term Klotho secretion in vitro.
- Field
- ageing and longevity
- What they did
- Researchers from Austria and the company Avaí Bio published an article confirming that their technology allows cells to produce the protein klotho for a long time in a lab setting.
- Why it matters
- This could be useful for treating age-related kidney, heart, and brain diseases, as klotho levels decline with age.
#klotho#aging#cell therapy#avaí bio
